DIB-V
Country: Australia
Language: English
Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)
Patient Information leaflet
(PIL)
20-02-2015
Send request.
Active ingredient:
PROGESTERONE
Available from:
SYNTEX S.A.
INN (International Name):
progesterone(1g/Dv)
Pharmaceutical form:
MISC. INTRA VAGINAL/UTERINE PREP/DEVICE
Composition:
PROGESTERONE STEROID-PROGESTIN Active 1.0 g/Dv
Units in package:
10 x 30g; devices
Class:
VM - Veterinary Medicine
Therapeutic group:
COW | HEIFER | BOVINE | FEMALE CATTLE
Therapeutic area:
ENDOCRINE SYSTEM
Therapeutic indications:
POST-PARTUM ANOESTRUS | RE-SYNCHRONISATION OF OESTRUS | SYNCHRONISATION OF OESTRUS
Product summary:
Poison schedule: 5; Withholding period: WHP: Meat (0) days Milk (0) days. EXP ORT SLAUGHTER INTERVAL (ESI): Zero (0) days.; Host/pest details: COW: [POST-PARTUM ANOESTRUS, RE-SYNCHRONISATION OF OESTRUS, SYNCHRONISATION OF OESTRUS]; HEIFER: [POST-PARTUM ANOESTRUS, RE-SYNCHRONISATION OF OESTRUS, SYNCHRONISATION OF OESTRUS]; For synchronisation of oestrus, treatment of post-partum anoestrus and resynchronisation of oestrus in cows/mares.Remove inserts at least 24 hours before slaughter. See Contraindications, etc. on label
Authorization status:
Registered
Authorization date:
2023-07-01
Patient Information leaflet
SYNTEX S.A.
DIB-V
62744/101560
COMPANY NAME:
PRODUCT NAME:
APVMA APPROVAL NO:
LABEL NAME:
DIB-V
SIGNAL HEADINGS:
CAUTION
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
CONSTITUENT
STATEMENTS:
1 g/Dv PROGESTERONE
CLAIMS:
Intravaginal progesterone device for the regulation of oestrus,
treatment of post-partum
anoestrus and reduction of calving to conception interval in heifers
and cows.
NET CONTENTS:
10 x 30g devices
DIRECTIONS FOR USE:
RESTRAINTS:
CONTRAINDICATIONS:
Contraindicated for use in sexually immature heifers.
Contraindicated for use in animals with genital infections or abnormal
genital tracts.
Contraindicated for use less than 21 days after calving.
PRECAUTIONS:
Animals in poor condition from illness, nutritional or management
stress may not respond.
Not licensed for re-use.
SIDE EFFECTS:
DOSAGE AND
ADMINISTRATION:
Oestrus synchronisation and resynchronisation programs and those
designed for the
treatment of post-partum anoestrus in cows should be carried out in
consultation with a
registered veterinarian.
1. FOR SYNCHRONISATION OF OESTRUS
Insert DIB-V using an approved applicator. Inject the cow with 2 mg of
oestradiol benzoate
at insertion. Remove the DIB-V 7 days after insertion and inject cow
with PGF2a (or RLP APPROVED
For Official Use Only
analogue) at manufacturer's recommended dose. Administer 1 mg
oestradiol benzoate 24
hours later. If fixed time AI is to be used then it should be carried
out at 52-56 hours after
device removal.
2. TREATMENT OF POST-PARTUM ANOESTRUS
Insert DIB-V using an approved applicator. Inject the cow with 2 mg of
oestradiol benzoate
at insertion. Remove the DIB-V 8 days after insertion and inject cow
with PGF2a (or
analogue) at manufacturer's recommended dose and 400 to 500IU of
equine chorionic
gonadotrophin. Administer 1 mg of oestradiol benzoate 24 hours after
device removal.
3. RESYNCHRONISATION OF OESTRUS
Insert a new DIB-V using an approved applicator 13 days after the
first insemination. Inject
the cow with 1 mg of oestradiol benzoate at the time of insert
Read the complete document
